Fifty Years — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
eFlow extracts lithium from dilute brines in North America using direct lithium extraction technology, serving the clean energy and electric vehicle supply chain.
CleantechEnergyNew MaterialsSan Bruno, US
Eric McShane(CEO and co-founder)Evan Gardner(CTO and co-founder)
Co-investorsBlack FlagHarpoon VenturesUnion Square Ventures (USV)Voyager Partners
Enoda develops synthetic cytokine receptors, called MIMICs, that link therapeutic "Signal 3" cytokine functions to controllable inputs to engineer cell therapies without systemic toxicity.
BiotechDeep TechLondon
Andrew John Scobie(Executive Officer, Director)Michael Chavez(Co-founder & CEO)Paul Finn(Co-founder & CTO)Paul B. Finn(Founder)inJennifer Urquhart(Executive Officer, Director)Jacqueline Elizabeth Porch(Executive Officer, Director)
Co-investorsMBX Capital
Red Queen Bio builds an AI-powered biodefense system that rapidly designs and manufactures countermeasures against emerging biological threats, enabling faster defensive responses to evolving pathogenic risks.
AI & Machine LearningBiotechDefense Tech
Hannu Rajaniemi(Executive Director)Nikolai Eroshenko(CEO)
Co-investorsCompoundLongeVCThe Venture CollectiveCerberus Ventures
Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.
AI & Machine LearningBiotechHealthtechSan Carlos, US
Yue Clare Lou(Co-Founder & CEO)inYue Lou(Executive Officer, Director)
BoardKevin Barrett(Director)Altar Munis(Director)
Co-investorsEisai Innovation, Inc.SBI HoldingsFREEFLOW
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.